NCT05478161View on ClinicalTrials.gov

Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis

NAActive, not recruitingINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

January 24, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

February 28, 2025

Conditions
Transcatheter Aortic Valve Implantation
Interventions
DEVICE

(ALLEGRA Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis

Implantation of the ALLEGRA Transcatheter Heart Valve in failing surgical bioprosthesis

Trial Locations (2)

36213

Hospital Alvaro Cunqueiro, Vigo

49214

Schüchtermann Klinik, Bad Rothenfelde

All Listed Sponsors
lead

NVT GmbH

INDUSTRY